PH12014501211B1 - Deodorant composition - Google Patents

Deodorant composition Download PDF

Info

Publication number
PH12014501211B1
PH12014501211B1 PH12014501211A PH12014501211A PH12014501211B1 PH 12014501211 B1 PH12014501211 B1 PH 12014501211B1 PH 12014501211 A PH12014501211 A PH 12014501211A PH 12014501211 A PH12014501211 A PH 12014501211A PH 12014501211 B1 PH12014501211 B1 PH 12014501211B1
Authority
PH
Philippines
Prior art keywords
copolymer
component
deodorant composition
composition
alkyl
Prior art date
Application number
PH12014501211A
Other versions
PH12014501211A1 (en
Inventor
Shinichi Nagashima
Yuriko Omoto
Koki Tomomatsu
Masahiko Fujiyama
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of PH12014501211A1 publication Critical patent/PH12014501211A1/en
Publication of PH12014501211B1 publication Critical patent/PH12014501211B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Provided is a deodorant composition comprising: (A) an antiperspirant component, and (B-1) an acrylic acid-based anionic polymer selected from among an ammonium (styrene/alkyl acrylate) copolymer, an ammonium alkyl acrylate copolymer, an octylamide acrylate-hydroxypropyl acrylate-butylaminoethyl methacrylate copolymer, an (alkyl acrylate/diacetone acrylamide) copolymer-amodimethicone, an (acrylates/(C1-18)alkyl acrylate/(C1-8)alkyl acrylamide) copolymer or a salt thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof, wherein the ratio of the content of the component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.

Description

I ——————— ¥ } alkyl acrylate/(Cy-g) alkyl acrylamide) copolymers or salts thereof, and (alkyl acrylate/diacetone acrylamide) copolymers or salts thereof.
Examples of (acrylates/(Ci-13) alkyl acrylate/(Ci-s) alkyl acrylamide) copolymers or salts thereof include (acrylates/ (Ci-13) alkyl acrylate/ (Cis) alkyl acrylamide) copolymer AMP (chemical name: 2-amino-2-methyl-l-propanol salt of alkyl esters of acrylic acid and methacrylic acid /alkyl acrylate/acrylamide copolymer; trade name:
Plascize L-9909B, from Goo Chemical Co., Ltd.; 40 wt %).
Examples of (alkyl acrylate/diacetone acrylamide) copolymers or salts thereof (alkyl acrylate/diacetone acrylamide) copolymer-AMPD (chemical name : 2-amino-2-methyl-1, 3-propanediol salt of alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; trade name:
Plascize L-1260, from Goo Chemical Co., Ltd.; 40 wt %), (alkyl acrylate/diacetone acrylamide) copolymer AMP (chemical name: 2-amino-2-methyl-l-propanol salt of alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; Plascize L-53P, from Goo Chemical Co., Ltd.; 50 wt %), and (alkyl acrylate/diacetone acrylamide) copolymer (chemical name: alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; trade name:
Plascize L-53, from Goo Chemical Co., Ltd.; 50 wt %).
These may be used singly or two or more may be used in combination. However, from the standpoint of the antiperspirant effect, ammonium (styrene/alkyl acrylate) copolymer, (acrylates/ (Ci-18) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer AMP and octylamide acrylate/hydroxypropyl acrylate/butyl aminoethyl methacrylate copolymer are preferred. From the standpoint of the stability of the preparation, (acrylates/(Ci-1s)
EE EEE —————————————e 1 } alkyl acrylate/(Ci-s) alkyl acrylamide) copolymer AMP and octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate copolymer are especially preferred.
From the standpoint of the antiperspirant effect and the prevention of sweat stains on clothing, the content of component (B-1) is preferably from 0.1 to 2.5 wt %, and more preferably from 0.3 to 2 wt %, of the overall composition. At a component (B-1) content of less than 0.1 wt %, the antiperspirant effect, duration of the antiperspirant effect and absence of sweat stains on clothing may be inadequate. On the other hand, at a content greater than 2.5 wt %, stickiness may occur, making use less pleasant, in addition to which the stability (absence of separation and settling) of the preparation may decrease. (B-2) Vinyl Acetate-Based Anionic Polymer
Illustrative examples of vinyl acetate-based anionic polymers include (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer (trade name: RESYN 28-2930, from AkzoNobel Japan), (vinyl methyl ether/ethyl maleate) copolymer (trade name: Gantrez ES-225, from ISP Japan
KK), and (vinyl methyl ether/butyl maleate) copolymer (Gantrez ES-425, from ISP Japan KK). From the standpoint of the antiperspirant effect, the durability of this effect and the absence of sweat stains, a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer is especially preferred. From the standpoint of the stability of the preparation, a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer are especially preferred.
From the standpoint of the antiperspirant effect, the content of component {B-2) is preferably from 0.1 to 5 wt %, and more preferably from 1 to 4 wt %. At a component (B-2) content below 0.1 wt %, the antiperspirant effect, -g-
y x durability of the antiperspirant effect and absence of sweat stains on clothing may become inadequate. On the other hand, at more than 5 wt $%, stickiness may arise, making use less pleasant, in addition to which the stability (absence of clouding, absence of settling) of the preparation may decrease.
A commercial product (un-neutralized product or neutralized product) may be used directly without modification as the anionic polymer in this invention.
Commercial products which are un-neutralized products may ! be rendered into salts using any alkali agent, and commercial products which are neutralized products may be desalinated using any acid. No particular limitations are imposed on the alkali agent or the acid, although in the case of an alkali agent, rendering into a salt using ammonium, 2-amino-2-methyl-1l-propanol (AMP) , 2-amino-2- methyl-1, 3-propanediol (AMPD) or the like as the alkali agent is preferred; in the case of an acid, desalination using hydrochloric acid, sulfuric acid or the like is preferred. The method of desalination may entail, for example, dissolving 1 g of (acrylates/ (Ci-1g) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer AMP (Plascize
L9909B, 40 wt %) in 4 g of ethanol (95 wt %). By adding to this 65 pL of hydrochloric acid and desalinating, an (acrylates/ (Ci-13) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer (35 wt %) may be obtained. In this invention, salts obtained using 2-amino-2-methyl-1l-propanol are abbreviated AMP, and salts obtained using 2-amino-2-methyl- 1, 3-propanediol are abbreviated AMPD.
In this invention, the effect of imparting durability or water resistance to the skin with component (A) differs depending on the type of component (B). Hence, from the standpoint of improving the antiperspirant effect, the duration of the antiperspirant effect and the prevention
3 1 of sweat stains on clothing, and also from the standpoint of the absence of stickiness, the optimal compounding ratios of component (A) with component (B-1) or component (B-2) are as follows.
In cases where component (B-1) is used, the ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5, and preferably from 0.04 to 0.75 by weight. When this ratio is less than 0.02, both the durability of the antiperspirant effect and also the sweat stain on clothing suppressing effect worsen. On the other hand, at more than 5, the antiperspirant effect and durability thereof and the sweat stain suppressing effect worsen. Also, the stability (absence of clouding, absence of settling) of the preparation over an extended period of time worsens depending on the compounding ratio of components (A) and (B-1). From the standpoint of stability, the compounding ratio is preferably from 0.02 to 1.0, and more preferably from 0.04 to 0.5.
In cases where component (B-2) is used, the ratio of component (B-2) to component (A), expressed as (B-2)/(A4), is from 0.05 to 10, and preferably from 0.1 to 1 by weight. At less than 0.05, the durability of the antiperspirant effect and the sweat stain preventing effect worsen, whereas at more than 10, the antiperspirant effect and its durability, as well as the sweat stain on clothing preventing effect, cease to be acceptable, in addition to which the absence of stickiness decreases.
Also, the stability (absence of clouding, absence of settling) of the preparation over an extended period of time worsens depending on the compounding ratio of components (A) and (B-2). From the standpoint of stability, the compounding ratio is preferably from 0.05 to 1.0, and more preferably from 0.1 to 0.5.
EEE ————————— eee errr 3 1 [ (C) Powder]
In this invention, by further including (C) a powder, the antiperspirant effect can be made to last longer and a long-lasting deodorizing effect against body odor due to perspiration can be obtained. Illustrative examples of the powder include magnesia-silica, silica, talc, nylon resin and silicone resin. A single powder may be used alone, or two or more powders may be used in combination.
Of these, from the standpoint of the deodorizing effect and the durability of the antiperspirant effect, magnesia- silica, silica and talc are preferred. The powder has an average particle diameter of preferably from 0.5 to 30 um.
From the standpoint of the durability of the deodorizing effect, the average particle diameter is more preferably from 2 to 25 pum. In this invention, the average particle diameter is a value measured with a laser diffraction-type particle size analyzer (Shimadzu Corporation, SALD-2200).
When component (C) is included, from the standpoint of the durability of the antiperspirant effect and the durability of the deodorizing effect, and especially the durability of the deodorizing effect, the content thereof is preferably from 0.1 to 5 wt %, and more preferably from 0.5 to 3 wt %. At less than 0.1 wt %, the durability of the deodorizing effect and the durability of the antiperspirant effect may be inadequate. At more than 5 wt %, whitening may occur.
In addition to the above components, any known ingredient customarily included in deodorant compositions may be suitably formulated according to the form and purpose of the composition, either singly or as a combination of two or more thereof, in the deodorant composition of the invention, insofar as doing so is not detrimental to the advantageous effects of the invention.
Examples include, for example, fats and oils, waxes,
¥ $ silicone oils, hydrocarbon oils, higher fatty acids, esters, higher alcohols, synthetic ester oils, surfactants, polymeric compounds other than component (B}, antioxidants, pigments, emulsion stabilizers, pH adjustors, astringents other than component (A), preservatives, ultraviolet absorbers, chelating agents, humectants, thickeners, algefacients, anti-inflammatory agents, bactericides, amino acids, vitamins, and various plant extracts.
Illustrative examples of higher fatty acids include stearic acid, linoleic acid, lauric acid, myristic acid, palmitic acid, behenic acid, lanolin acid, oleic acid, undecylenic acid and isostearic acid. These may be used singly or two or more may be used together.
Illustrative examples of esters include decyl oleate, butyl stearate, myristyl myristate, hexyl laurate, isopropyl palmitate, isopropyl myristate, octyldodecyl myristate, hexyldecyl dimethyloctanoate, diethyl phthalate, glycerol monostearate, glycerol trimyristate and cetyl lactate. These may be used singly or two or more may be used together.
Surfactants that may be used include nonionic surfactants, anionic surfactants, cationic surfactants and amphoteric surfactants. Of these, surfactants which do not cause skin conditions are preferred. Illustrative examples include surfactants such as soybean lecithin, egg yolk lecithin, saponin, oligoglycosides, phospholipid biosurfactants, acylpeptide biosurfactants, polyoxyethylene-polyoxypropylene glycol, polyoxyethylene-polyoxypropylene cetyl ether, polyoxyethylene-polyoxypropylene butyl ether, polyoxyethylene coconut oil fatty acid monoethanolamide, polyoxyethylene lauryl ether, triethanolamine polyoxyethylene lauryl ether sulfate, sodium
EE ———————————— errr — 1 3 polyoxyethylene lauryl ether sulfate, polyoxyethylene lauryl ether phosphoric acid, sodium polyoxyethylene lauryl ether phosphate, polyoxyethylene lanolin, polyoxyethylene lanolin alcohol, polyoxypropylene butyl ether, sodium polyphosphate, sorbitan monooleate, polyethylene glycol monooleate, polyoxyethylene sorbitan monooleate, polyethylene glycol monostearate, polyoxyethylene glycerol monostearate, polyoxyethylene sorbitan monostearate, sorbitan monopalmitate, polyoxyethylene sorbitan monopalmitate, sorbitan monolaurate, polyethylene glycol monolaurate, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbit monolaurate and coconut oil fatty acid diethanolamide. These may be used singly or two or more may be used together.
Illustrative examples of astringents include zinc sulfate, zinc phenolsulfonate, citric acid, tartaric acid, lactic acid, tannic acid and alum. These may be used singly or two or more may be used together.
Illustrative examples of humectants include glycerol, 1,3-butylene glycol, propylene glycol, 3-methyl-1,3- butanediol, 1, 3-propanediol, 2-methyl-1, 3-propanediol, pentaerythritol, hexylene glycol, diglycerol, polyglycerol, diethylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, sorbitol, xylitol, erythritol, mannitol, maltitol, glucose, fructose, galactose, mannose, threose, xylose, arabinose, maltose, trehalose, lactose, raffinose, a-, PB- and y-cyclodextrin, pectin, arabinogalactan, dextrin, dextran, glycogen, ethyl glucoside, hyaluronic acid, sodium hyaluronate, urea, trimethylglycine, arginine, lysine, serine, glycine, alanine, phenylalanine, tyrosine,
B-alanine, threonine, glutamic acid, glutamine,
I ———————— 3 3 asparagine, aspartic acid, cysteine, cystine, methionine, leucine, isoleucine, valine, tryptophan, histidine, taurine and hydrolyzed collagen. These may be used singly or two or more may be used together.
Illustrative examples of polymeric compounds and thickeners include guar gum, locust bean gum, quince seed, galactan, gum arabic, tara gum, pectin, xanthan gum, pullulan, gellan gum, chitin, chitosan, agar, casein, collagen, gelatin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl hydroxypropyl cellulose, soluble starch, methylhydroxypropyl starch, propylene glycol alginate, polyvinyl alcohol (PVA), polyoxyethylene-polyoxypropylene copolymer, (dimethicone/vinyl dimethicone) Cross polymer and cationized cellulose. These may be used singly or two or more may be used together.
The algefacient is not particularly limited, and may be suitably selected according to the intended purpose.
Illustrative examples include l-menthol, l-menthyl glyceryl ether and l-menthyl lactate. These may be used singly or two or more may be used together.
No particular limitation is imposed on embodiments of the deodorant composition of the invention. Application as, for example, a cosmetic material, a drug or a quasi- drug is possible. Use as a personal deodorant composition such as for the underarm area is also possible. The form of the inventive deodorant composition is exemplified by various types, such as that of a solid, semi-solid, gel, liquid or cream, preparation being possible based on the customary methods for these forms. In addition, in the practice of this invention, preparation 1s possible by formulating the respective ingredients in a continuous solvent phase (single layer). Specifically, rendering the deodorant composition of the invention into, for example,
=e =e eee ee meee rrr
J ¥ a roll-on product, gel, lotion, mist, stick, cream, sheet or deodorant foundation is preferred. From the standpoint of the durability of the antiperspirant effect and the durability of the deodorizing effect, a roll-on product, gel, lotion or mist is more preferred.
In particular, applying the composition of the invention to the skin in a water-dissolved state is effective for exhibiting the effects thereof. As liquid- type forms such as roll-on products, gels, lotions and mists, preferred use can be made of roll-on type, gel type and lotion type preparations because they can be closely applied and are able to exhibit highly advantageous effects. The deodorant composition of the invention is preferably rendered into a deodorant composition for filling into a roll-on container, a deodorant product obtained by filling the deodorant composition into a roll- on container, or a liquid antiperspirant deodorant product composed of a deodorant composition and a roll-on container having an applicator ball filled with this composition. A roll-on type preparation is housed in a commonly known roll-on container; the deodorant composition can be applied by transferring the composition to the ball which is rotatably held in a partially exposed state on the container by a holder, and bringing the ball into contact with the skin at the time of use. It is also preferable to render the deodorant composition into the form of a gel which is filled into a bottle-type container and applied directly using the container, or into the form of a gel or lotion which is applied using the fingertips or hand.
The method of preparing the deodorant composition of the invention is not particularly limited and may be suitably selected according to the intended purpose. The deodorant composition can be obtained by mixing components
3 J (A) and (B), and also, where necessary, component (C) and optional ingredients, together with ethanol and water (which are included as the balance of the composition so that the overall amount of deodorant composition becomes 100 wt %).
EXAMPLES
The invention is illustrated more concretely below by way of Working Examples and Comparative Examples, although the invention is not limited by these Examples. In the
Examples that follow, the amount of each ingredient is shown as the content thereof expressed in terms of the pure ingredient. [Examples 1 to 80 and Comparative Examples 1 to 9]
Deodorant compositions (roll-on) formulated as shown in the tables below were prepared in the usual manner, 40 mL of the respective compositions were filled into roll-on containers having the specifications indicated below, and the evaluations described below were carried out. The results are presented in the tables. <Bottle> Yoshino Kogyosho KK
Material: HDPE Natural Capacity when full approx. 56 mL
Body diameter approx. ¢ 33 mm Height approx. 87 mm <Ring> Yoshino Kogyosho KK
Material: LLDPE Natural Outside diameter approx. 26 mm
Height approx. 18 mm <Ball> Yoshino Kogyosho KK
Material: PP White Diameter approx. 20 mm [Antiperspirant Effect]
Method of Evaluation
EE I —————————————— ree. } i
Each sample was applied in an amount of about 0.1 g to a region (length by width: 3 cm x 3 cm) on the inside of the forearm on 20 female subjects ranging in age from the twenties to thirties. After the samples had dried, the subjects carried out 15 minutes of light exercise in a 35°C, 70% RH environment. Next, the amounts of perspiration in the area where a sample was applied and in an untreated area were measured using a perspiration meter (SKN-200, from Nishizawa Electric Meters Manufacturing
Co., Ltd.), and the antiperspirant ratio was determined from the following formula. The results are indicated as average values for the 20 subjects. [Mathematical Formula 1]
Sweat suppression ratio (%) = 100 - [amount of perspiration (mg/min) in treated area/ amount of perspiration (mg/min) in untreated area] x 100
Rating Criteria ©: Sweat suppression ratio was 81 to 100%
QO: Sweat suppression ratio was 61 to 80%
A: Sweat suppression ratio was 41 to 60% x: Sweat suppression ratio was 0 to 40% [Duration of Antiperspirant Effect (antiperspirant effect after 8 hours)
Method of Evaluation
The durability of the antiperspirant effect was evaluated in 20 female subjects ranging in age from the : twenties to the thirties who use deodorants. Each sample
TE ———— —————————— eee rrr
C 5) was applied as a roll-on preparation in an amount of 0.2 g to the underarm area in the morning, and the amount of perspirant 8 hours later was measured in the same way as described above. The sweat suppression ratio was determined from the above formula. The rating results, So indicate the average value for the 20 subjects. . p < [Absence of Sweat Stains on Clothing, Absence Y: 2, !
Stickiness, Durability of Deodorizing Effect] c
The absence of sweat stains on clothing, the absence . of stickiness and the durability of the deodorizing effegt were evaluated in 20 female subjects ranging in age from the twenties to the thirties who use deodorants. Each sample was applied as a roll-on preparation in an/amount of 0.2 g to the underarm area in the morning, and evaluations were carried out by the following methods. (Absence of Sweat Stains on Clothing)
Method of Evaluation
At the time that the subjects sensed they were perspiring the most, the subjects themselves carried out a visual evaluation of sweat stains on the underarm areas of the T-shirts they were wearing. <Rating Criteria>
Number of subjects who decided that they had no sweat stains. ©: 16 to 20
Oo: 11 to 15
A: 6 to 10 x: 0 to 5 (Absence of Stickiness)
Method of Evaluation
EE ————————————— EE —————————————reeeeeesr error. 1 i
The absence of stickiness following application of the deodorant was evaluated by the subjects themselves.
Rating Criteria
Number of subjects who decided that they were free of stickiness. ©: 16 to 20
OO: 11 to 15
A: 6 to 10 x: 0 to 5 (Durability of Deodorizing Effect)
Method of Evaluation
Each subject applied the roll-on preparation to one underarm area, then put on a T-shirt having prewashed pieces of gauze (5 cm x 5 cm) sewn onto both underarm areas. After the T-shirts had been worn for 8 hours, the shirts were recovered and the worn gauzes were subjected to odor evaluations in which each judge on a five-person panel carried out sensory evaluations for each of the 20 subjects, comparing the gauze at the treated site with the gauze at the untreated site (the underarm on the other, untreated side). The results obtained by calculating the average score of the odor evaluations for 20 pieces of worn gauze were rated according to the criteria indicated below. The subjects were not permitted to use other antiperspirants starting 3 days before application, and were asked to use an unscented body soap on the day prior to application.
Scoring Criteria 5 points: No odor whatsoever compared with untreated site
¥ 1 4 points: Substantially no odor compared with untreated site 3 points: Slight odor compared with untreated site 2 points: Discernible but small odor from untreated site 1 point: Odor is of the same degree or greater than that at untreated site
Rating Criteria ©: At least 4 points and up to 5 points
O: At least 3 points but less than 4 points
A: At least 2 points but less than 3 points x: At least 1 point but less than 2 points
EE ——————————__ - : = [Table 1] meme
Formulation (wt %) elas ee (A) chlorohydroxyaluminum- 2.0 propylene glycol complex ’ chlorohydroxyaluminum/ 2.0 zirconium-glycine complex :
Ammonium (styrene/ alkyl acrylate) copolymer 1.0 1.0 1.0 0.5 1.0 1.0 1.0 (B-1)
Ammonium alkyl acrylate 1.0 copolymer .
Teoprony? nett ehenet 2 or a glyceryl Sher 8 3
Fraronypropyl ceintose o a
Re a Fragrance :
S Frhanet = " Y roritisn ores Lote tannins
Antiperspirant effect : °olojofojojo]o]e ~ 0 FE 0 Durability of 8 3 > Absence of sweat stains
EEE ——————— EE ————————————— eee reer ¥ ’ [Table 2] eee
Formulation (wt $%) oo fue ]n fuse]
Chlorohydroxy- oo |store ooo] 20] 202s] so] 0s] s0] 0 uo)
Ammonium (B~1)| (styrene/alkyl 0.1 2.5 0.5 1.5 0.51 2.0 2.5 0.5 1.0 2.0 acrylate) copolymer
Isopropyl methyl phenol 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
POP (17) glyceryl 2 ether 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 [1.0 1.0 = o Hydroxypropyl bi o o - o | Fragrance 0.4 :
S Frhanod he " Y roricios voter |e] re] mir] mir] ie] is ire ire rs ire
Antiperspirant n | effect (instrument © © © © © © © © | evaluation) 3 ¢ | Durability of
H | antiperspirant © © © © © © © a effect 5
Y | Absence of [ol 5] Absence of sweat
EEE —————————————————eeeeer eee ¥ + [Table 3] eee
Formulation (wt $%)
EEE
_ Ammonium (styrene/alkyl 1 1.0 (B-1) acrylate) copolymer 1.0 1.0 1.0 1.0 1.0 .0 sressacmities J za | [| Jos] a0 sae Jee en ee a2] ssc sn |] ee)
Teopropy: meth phenol 0
S b Frdroxypropyl celiutose o o --
E
Fehanol o vt * socitied water ten taessnacnmetaes ntre i
Antiperspirant effect meni, [0 [oe [6 | 0000 0
Pp im Durability of 9 2 5 3 Absence of sweat stains £m
Durability of
=P —————— eee eee eee arr err.
Y ' [Table 4]
Comparative Example
Formulation (wt %) eae se] chorenydroxyatuminun 20 | 20 | - | eo woo | ou _ Ammonium (styrene/ 2.5 (B-1) alkyl acrylate) copolymer 1.0 0.1 (Methyl vinyl ether/ maleic anhydride) 1.0 copolymer ' (8) PER (Styrene/isoprene/styrene 1.0 ) block copolymer :
Teopropyt mer phenol § - : yerorypropyt cetiutose o c — a Fragrance = :
S Frhanol oe vt ? rors unter omtece onan tone sce ance stace o Antiperspirant effect © £2 (instrument evaluation) = ¢ | Durability of
H antiperspirant effect § ; -—
E Absence of sweat stains on clothing
I —————————— x + [Table 5] meme
Formulation (wt %) [oo [wm ow] 22 (3) Chlorohydroxyaluminum- 2 propylene glycol complex
Chlorohydroxyaluminum/ 2 zirconium-glycine complex (Acrylates/ (Ci-15) alkyl (B-1) [| acrylate/ (Cy) alkyl 1 1 1 0.5 1 1 1 acrylamide) copolymer AMP reopropy? ret phenol 3 or or glyeeyt Sher § -—
E yarorypropy! cetiutose oO a -— a Fragrance 0.4
E
S Fehanod °° vt Y ee
Antiperspirant effect : o|ojojojofo]e = 0 . o Durability of py antiperspirant effect © ooo] © © © 8 3 > Absence of sweat stains
EE ee ——————— ——— EE {Table 6] ’
Formulation (wt $%) Ce . pl oo ” 4 chiorohydronyatuminin i (Acrylates/ (C,_13) alkyl acrylate/ Vi << (Cig) alkyl acrylamide) copolymer AMP Se (Alkyl acrylate/diacetone : acrylamide) copolymer- 1 amodimethicone /
Octylamide acrylate-hydroxypropyl (B-1) acrylate-butylaminoethyl 1 methacrylate copolymer (Alkyl acrylate/diacetone 1 acrylamide) copolymer AMPD (Alkyl acrylate/diacetone 1 acrylamide) copolymer reopropt rer phenol 2 or tn oryeent erie 8 -~ : arerypropyl eel ulose o c -— o Fragrance :
S Frhaned to " ?
Antiperspirant effect 8 (instrument evaluation) © © © 3 ® | Durability of antiperspirant ©
H effect o 3 3 Absence of sweat stains on © clothing —-0 6
EEE ———————————— eee t £ [Table 7]
Formulation (wt %) aw [we |e _ (Acrylates/ (Cy-15) alkyl acrylate/ (B-1) (Cig) alkyl acrylamide) copolymer AMP 0.1 2.5 0.3 1.5
Teopropy: ret phenol g or or Flyeenyt Sher 8 -~ ; Pyaroxypropyl seuss o a -— a Fragrance :
Antiperspirant effect 8 (instrument evaluation) © © © © 7 : a > antiperspirant srrect oe | 0 | eo o 3 2 g 3 Absence of sweat stains - clothing oe] eo] eo
EE ————————————— eee eee ______
X ¥ [Table 8]
Formulation (wt %)
Shioronydroxyaluminin (Acrylates/ (C;.15) alkyl (B-1)| acrylate/ (Cys) alkyl 0.1 2 2.5 0.5 1 1 acrylamide) copolymer AMP reopropy? ret phenol 2 TF wr grycesyt ether 6 a f ydroxypropyd cellulose g -— :
Antiperspirant effect : o|ojofolejo]e = n 0 Durability of . antiperspirant effect (o]olofoefe|o|e 8 3 > Absence of sweat stains
Even when the ratio in Example 42 was changed to 0.02, the same results as in Example 42 were obtained.
I ———— eer ereemeeeoeer—————____ 1. x } [Table 9]
Formulation (wt $%) [wa waa] (Acrylates/(C;-15) alkyl (B~1) { acrylate/ (Cig) alkyl 1 1 1 1 1 1 1 acrylamide) copolymer AMP
Teopropyt methyl phenol 0) a g pa a Fragrance 2 : 8 Srhanel os ve >
Antiperspirant effect (instrument evaluation) © © © © © © © wn
D
~ Durability of “9 8
A
42 3 Absence of sweat stains o | on clothing © © © © © © © a
EE ———————————————er er. _ i x [Table 10]
Formulation (wt $%)
BEE EERE chiorehydronyaiuminin 2020 [20 | wo fos | anno] 0s] _ (VA/crotonic acid/vinyl neodecanoate) copolymer 0.1 5.0 1.0 oo 5.0 0.5 2.0 2.5
Teopropy: meth phenol : oF or pryeenyt other a b Hyrorypropyt cetiutose o a
A
:
S Frhenel o " Y
Antiperspirant effect 8 (Instrument evaluation) © © © © © | © (oo = 0 Co 0 Durability of 3 i & Absence of sweat stains on clothing (o|o]efefo]o|o]o
EE ————————————————eeeeeeeer——————___.. _ ro & [Table 11]
Formulation (wt $%) crorohydronyaluminun _ (VA/crotonic acid/vinyl (B-2) neodecanoate) copolymer 1.5 2.0 1.0 3.0 recpropyt nett phenot 2 wr tr Flyers: Srher 8 -~ : Fydrorypropy cetiutose o a -— :
Antiperspirant effect a (instrument evaluation) © © © © © 3 wn . o Durability of - antiperspirant effect 8 > Absence of sweat stains x «2 [Table 12]
Formulation (wt %)
EERIE crorehydroxyaiuminen a (VA/crotonic acid/vinyl (B-2) neodecancate) copolymer 1.0 1.0 1.0 1.0 1.0 1.0 1.0 reopropy: methyl phenol 0 a
Pydronypropyt celintose g -— o Fragrance = :
Antiperspirant effect wn
Pp = Durability of pe © a 5 Absence of sweat stains s on clothing © © © © © © ©
I
Durability of
TE ——————————— y ' 4 [Table 13]
Comparative Example
Formulation (wt $%) ee chiorohydroryaluminun EEE (B-2) (VA/crotonic acid/vinyl neodecanoate) copolymer recpropvt rer phenot > slveent srher ydronypropyl celiutose
Common ingredients
Fragrance
Frhanel he ?
Antiperspirant effect © (instrument evaluation)
Durability of antiperspirant effect x | a | oo
Evaluation results
Absence of stickiness
Absence of sweat stains on clothing | x | a ee —————————————— 3 ¢ } [Table 14] eee
Formulation (wt %) en me] = choronydroxyatuninun (Vinyl methyl ether/ethyl maleate) 0.1 copolymer : (B-2) (Vinyl methyl ether/butyl maleate) 0.1 1 3 copolymer : reopropy! rere phenol 2 Fo wr slyceryt erher 8 -— g ydroxypropyl celiutose on a rl :
S Frhenod 0 " ?
EE Ee ee
Antiperspirant effect 3 |Msenasit, | ooo |oe oe 3 a Durability of antiperspirant ©
H effect © 3 g sosence cr suscuiness | 0 | 0 | © | 0 | 0 3 Absence of sweat stains on © clothing [Examples 81 to 98]
The following deodorant compositions (roll-on) formulated as in Examples 26, 31, 32, 40, 41, 45 to 48, 35, 58, 59, 64 to 68 and 80 were prepared in the same way as in these examples. As shown below, the compositions of the invention had excellent preparation stabilities over a long period of time.
a ——— ¥ O 3 [Stability of Preparation]
Method of Evaluation
Each sample in an amount of 40 mL was placed in a glass bottle and the appearance was observed immediately following sample preparation (suitability for compounding: initial stability), after one month of storage at 40°C and 75% RH (stability over time, short-term), and after three months of storage (stability over time, long-term).
Rating Criteria ©: Clear
QO: Substantially clear
A: Slight clouding or turbidity x: Turbidity and/or settling [Table 15] meme
Formulation me ® BEER (Example | (Example | (Example | (Example | (Example 26) 31) 32) 40) 41) ortoromoroatomion | 5 [ws | 0 | 2 | 2 (Acrylates/ (C;-13) alkyl acrylate/ (B-1)| (Cis) alkyl acrylamide) 1 1 1 0.3 1.5 copolymer AMP swoon sem erat | 0x | 0a | oa | oa | oa : 8 -— § g -—
Oo :
O Ethanol (95 wt %) 70 70 70 70 70
EE
EE ————————— es —————_ a iH i
Stability: Suitability for “ compounding © © © © ©
Oo (initial stability) -r joe Co ®'5 | Stability: Over time - short-term:
Sa 10°C, 1 M © © © © © 3 “ © . . .
Stability: Over time - long-term: : 10°¢, 3M 0] ofo |e] oo]
{. «
DEODORANT CC
TECHNICAL FIELD
The present inventi composition.
BACKGROUND ART
In recent years, ar uneasy about their body odor, anu for a higher body odor Suppressi... antiperspirants. In order to suppress body odor, - very effective to suppress perspiration, which is an odor- causing substance. Most antiperspirants currently on the market use the sweat gland obstructing action of chlorohydroxyaluminum as the technique for reducing perspiration.
However, it is often the case today that when the amount of perspiration is large, the antiperspirant effect is inadequate and odor becomes a concern.
Prior-art documents relating to this invention are given below.
CITATION LIST
Patent Documents
Patent Document 1: JP-A 2005-536477
Patent Document 2: JP-A 10-500711
Patent Document 3: JP-A 2004-517093
Patent Document 4: JP-A 8-34718
Patent Document 5: JP-A 2-290810
Patent Document 6: JP-A 2010-70553
Patent Document 7: JP-A 2000-86476
HE ———————————————————— a 0 [Table 16]
Formutation me Y oo | ow [sw (Example | (Example | (Example | (Example | (Example 45) 46) 47) 48) 35) (Acrylates/ (Ci.15) alkyl acrylate/ (C1-3) alkyl acrylamide) 0.5 1 1 copolymer AMP (B-1) (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl 1 methacrylate) copolymer 2 or vr styeesyt ether 5 fs yaronypropyt celintose o o -H : 5 Frhanol oe i ?
Stability: Suitability for compounding © © © © © o (initial stability) © wn an
PP Daa . os | Stability: Over time - short-term:
Aa 40°C, 1 M © © © © ©
Sf = Stabilit O ti 1 t ability: Over time - long-term: 40°C, 3 M © © © © ©
EEE ——————————————
[7] (yd [Table 17]
Formulation ve Y a [a | a | w (Example | (Example | (Example | {Example 58) 59) 64) 65) chiorohydroxyaluninun ee es opoiimer seri ecdeseneate BREE copolymer
Teopropyt ner phenol & or vr gryeeyt ether 8 - § yaronypropyl celtutose o o -— :
S Frhaned 0 " Y
Stability: Suitability for compounding g (initial stability) © © © © oH 0 £5 | stability: over time - short-term: 32 Ye, 1m © © © © — ’ oO
NY
= Stability: Over time - long-term: sie guru semen | 0 | 0 | 0 |e
= ————————— eee eet epee
Eootv [Table 18]
Fomutation me * EERE EE (Example | (Example | (Example | (Example 66) 67) 68) 80) chioronydroxyatuninun (VA/crotonic acid/vinyl neodecanoate) 1 3 copolymer (B-2) (Vinyl methyl ether/butyl maleate) 3 copolymer
Tecpropyt mer phenet 7 oF or sryeenyt Sher § 3 ydronypropyl celiuiose o a -H g
S Frhanet oe " ?
Stability: Suitability for compounding g (initial stability) © © © © or 0 £45 | stability: Over time - short-term: 33 Ygee, 1m © © © © — r 5 0
SH
= Stability: Over time - long-term:
&® £9 3 [Example 99] Deodorant Mist (trigger-type container)
A 100 mL amount of the sample was filled into a trigger-type spray container (average diameter of spray holes: 0.45 mm; trigger: Zz-305, from Mitani Valve Co.,
Ltd.; polyethylene container: PH-100, from Kamimura
Kagaku Kogyo KK), and evaluations were carried out in the same way as described above. [Table 19] !
Chioronydroxyatuminun
Ammonium (styrene/alkyl acrylate) copolymer
Isopropyl methyl phenol
POP (17) glyceryl ether
Hydroxypropyl cellulose
Common ingredients snc es ities wmser | eee
Antiperspirant effect (instrument evaluation)
Evaluation results Durability of antiperspirant effect for pleasantness
Absence of sweat stains on clothing yo) [Examples 100 to 102] Deodorant Gels (bottle-type container)
In each example, 20 mL of the sample was filled into a bottle-type container (TOM-30, with inside plug (Nozzle
B for TO cap)), and evaluations were carried out in the same way as described above. [Table 20]
Formulation (wt $%) chiorohydroxyaluninun BIIEX (Acrylates/ (Ci.14) alkyl acrylate/ 0.7 0.5 (C15) alkyl acrylamide) copolymer AMP : : (B-1) (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) 0.5 copolymer
Stearyl trimethylammonium chloride (50 wt $%)
Aydroxypropyl cellulose
Common ingredients
Fragrance 0.3 0.3
Ethanol os vt ¥ : Antiperspirant effect (instrument evaluation)
Evaluation Durability of antiperspirant effect results for pleasantness of use Absence of stickiness © © ©
Absence of sweat stains on clothing
Suitability for compounding } (initial stability) © © ©
Evaluation fesults Over time - short-term: 40°C, 1 M stability over time } Long-term: 1c, > "
Se - iL -» [Example 103] Deodorant Lotion (bottle-type container)
The sample in an amount of 40 mL was filled into a bottle-type container (TOMIII-50, with inside plug (Nozzle
A for TO cap)), and evaluations were carried out in the same way as described above. [Table 21] 1
Formulation (wt $%) Be © chiorofydroxyaluninum (Acrylates/(Ci.13) alkyl acrylate/ (Cg) alkyl acrylamide) (B-1) 0.5 copolymer AMP
Isopropyl methyl phenol
POP (17) glyceryl ether
Hydroxypropyl cellulose
Common ingredients
Fragrance 0.5
Ethanol (95 wt %)
Antiperspirant effect (instrument evaluation)
Evaluation Durability of antiperspirant effect results for pleasantness of use Absence of stickiness ©
Absence of sweat stains on clothing ; Suitability for compounding (initial stability)
Evaluation results for Over time - short-term: 40°C, 1 M © stability
Over time - long-term: 40°C, 3 M
[JE 4)
Details on the starting materials used in the
Examples and the Comparative Examples are given in the following table. [Table 22] 5 5 Trade Ingredient
Armonium (styrene/alkyl acrylate) Yodosol 45 wt % copolymer GH41F AkzoNobel Japan aqueous solution
Ammonium alkyl acrylate Yodosol 45 wt %
GHB OOF Alzotionel Japan aqueous solution (Acrylates/ (Ci-15) alkyl acrylate/ . . AMP-neutralized (Cys) alkyl acrylamide) Plascize Goo Chemical 40 wt % copolymer AMP 0. : ethanol solution (Acrylates/ (Ci) alkyl acrylate/ Plus size 1-9909B . (Ci-g) alkyl acrylamide) copolymer was desalinated using 1-8 polym hydrochloric acid (Alkyl acrylate/diacetone acrylamide) SETSIL314 Dow Corning 2 t/a ueous copolymer-amodimethicone Toray Co., Ltd. solution a (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl Pa pEONER AkzoNobel Japan methacrylate) copolymer (Alkyl acrylate/diacetone Plascize Goo Chemical AMPD-neutralized acrylamide) copolymer AMPD L-1260 Co., Ltd. ethanol solution (Alkyl acrylate/ Plascize Goo Chemical 50 wt $% diacetone acrylamide) copolymer | L-53 Co., Ltd. ethanol solution (VA/crotonic acid/ RESYN vinyl neodecanocate) copolymer 28-2930 AkzoNobel Japan (Vinyl methyl ether/ Gantrez ISP ethyl maleate) copolymer ES-225 (Vinyl methyl ether/ Gantrez 1p butyl maleate) copolymer ES-425 . os Mizusawa
Magnesia-silica , : ; : Mizupearl Industrial (average particle Stee. ’ um) isons Chemicals, Ltd.
Silica porous particles Sunsphere AGC Si-Tech (average particle size, 12 um) H122 Co., Ltd.
Talc i (average particle size, 24 pm) Aoada seifun IE
Silicone powder Tospearl . (average particle size, > pm) 150 KA ones
Non-porous nylon beads Mukoshitsu | Miyoshi Kasei, (average particle size, 5 um) Nylon 12 Inc. (Methyl vinyl ether/ Gantrez ISP maleic anhydride) copolymer AN-119 (Styrene/isoprene/styrene) Cariflex . block copolymer TR1111 Shell Chemical
§ A
SUMMARY OF INVENTION Technical Problem
It is therefore an object of this invention to provide a deodorant composition which has a satisfactory antiperspirant effect that is also long-lasting, holds down stickiness, 1s able to prevent sweat 'stains on clothing and moreover has a long-lasting deodorizing effect against body odor due to perspiration.
Solution to Problem
The inventors have conducted extensive investigations, as a result of which they have discovered that by using together both an antiperspirant component and a specific anionic polymer, an increased antiperspirant effect is achieved and this antiperspirant effect lasts a long time, in addition to which stickiness is suppressed and sweat stains on clothing can be prevented. Moreover, the inventors have found that by adding also a powder, a deodorant composition that has a long-lasting deodorizing effect against body odor due to perspiration can be obtained.
Accordingly, the invention provides the following deodorant composition.
[1] A deodorant composition characterized by including: (A) an antiperspirant component, and (B-1) an acrylic acid-based anionic polymer selected from among an ammonium (styrene/alkyl acrylate) copolymer, an ammonium alkyl acrylate copolymer, an (octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) copolymer, an (alkyl acrylatg/diacetone acrylamide) copolymer-amodimethicone, an (acrylates/(Cji-1g) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer or a salt
EEE —— EE ——— er ere er ————————— { «
DEODORANT COMPOSITION
TECHNICAL FIELD
The present invention relates to a deodorant composition.
BACKGROUND ART
In recent years, an increasing number of people feel uneasy about their body odor, and so there exists a desire for a higher body odor suppressing effect in antiperspirants. In order to suppress body odor, it is very effective to suppress perspiration, which is an odor- causing substance. Most antiperspirants currently on the market use the sweat gland obstructing action of chlorohydroxyaluminum as the technique for reducing perspiration.
However, it is often the case today that when the amount of perspiration is large, the antiperspirant effect is inadequate and odor becomes a concern.
Prior-art documents relating to this invention are given below.
CITATION LIST
Patent Documents
Patent Document 1: JP-A 2005-536477
Patent Document 2: JP-A 10-500711
Patent Document 3: JP-A 2004-517093
Patent Document 4: JP-A 8-34718
Patent Document 5: JP-A 2-250810
Patent Document 6: JP-A 2010-70553
Patent Document 7: JP-A 2000-86476
I A thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof; wherein the weight ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.
[2] The deodorant composition of [1], wherein the salt of an (acrylates/(C;-18) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer is the 2-amino-2-methyl-l-propanol salt of an (acrylates/(Ci-13) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer, and the salt of an (alkyl acrylate/diacetone acrylamide) copolymer is the 2-amino-2-methyl-1, 3- propanediol salt of an (alkyl acrylate/diacetone acrylamide) copolymer.
[3] The deodorant composition of [1] or [2], wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-1) is from 0.3 to 2 wt % of the overall composition.
[4] A deodorant composition characterized by including: (A) an antiperspirant component, and (B-2) a vinyl acetate-based anionic polymer selected from among a (vinyl acetate/crotonic acid/vinyl neodecanocate) copolymer, a (vinyl methyl ether/ethyl maleate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer; wherein the weight ratio of component (B-2) to component (A), expressed as (B-2)/(A), is from 0.05 to 10.
[5] The deodorant composition of [4], wherein component (B-2) is a (vinyl acetate/crotonic acid/vinyl neodecanocate) copolymer.
[6] The deodorant composition of [4] or [5], wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-2) is from 1 to 4 wt % of the overall composition.
[7] The deodorant composition of any one of [1] to [6], wherein component (A) is chlorohydroxyaluminum.
a ———————————— EE ————
X x
[8] The deodorant composition of any one of [1] to [7] which further comprises (C) a powder.
[9] The deodorant composition of [8], wherein component (C) is a powder selected from among talc and magnesia- silica.
Advantageous Effects of Invention
This invention is able to provide a deodorant composition which has a high antiperspirant effect and maintains the antiperspirant effect for a long time, holds ! down stickiness, and can prevent sweat stains on clothing.
This invention is able to provide also a deodorant composition which, in addition to these qualities, has moreover a long-lasting deodorizing effect against body odor due to perspiration.
DESCRIPTION OF EMBODIMENTS
[{(A) Antiperspirant Component]
The antiperspirant component is not subject to any particular limitation, provided it is a component that imparts an antiperspirant effect. Illustrative examples include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, chlorohydroxyaluminum-propylene glycol complexes and chlorohydroxyaluminum/zirconium-glycine complexes. These may be used singly or two or more may be used in combination. Of these, from the standpoint of the antiperspirant effects, chlorohydroxyaluminum, a chlorohydroxyaluminum-propylene glycol complex or a chlorohydroxyaluminum/zirconium-glycine complex is preferred. Chlorohydroxyaluminum is especially preferred.
EE ———————— eee ere. 1 3
The content of component (A), from the standpoint of the antiperspirant effect, is preferably from 0.1 to 15 wt %, and more preferably from 1.5 to 10 wt %, of the overall composition. At less than 0.1 wt %, the antiperspirant effect and its durability, and also the sweat stain suppressing effect, may be inadequate. On the other hand, a content of more than 15 wt % may lead to a decline in the absence of stickiness, a worsening of skin irritation or inferior stability (absence of clouding, absence of settling) of the preparation. [(B) Anionic Polymer]
An anionic polymer is formulated in order to, through interaction with the antiperspirant component (7), increase the antiperspirant effect and prevent sweat stains on clothing. As this anionic polymer, preferred use can be made of (B-1) an acrylic acid-based polymer or (B-2) a vinyl acetate-based polymer. (B-1) Acrylic Acid-Based Anionic Polymer
The acrylic acid-based anionic polymer is exemplified by an ammonium (styrene/alkyl acrylate) copolymer (trade name: Yodosol GH41lF, available from AkzoNobel Japan, 45 wt %), an ammonium alkyl acrylate copolymer (trade name:
Yodosol GH800F, available from AkzoNobel Japan, 45 wt %), an (octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) copolymer (trade name: AMPHOMER 28-4910, available from AkzoNobel Japan), an (alkyl acrylate/diacetone acrylamide) copolymer- amodimethicone (chemical name: mixture of alkyl acrylate- alkyl methacrylate-diacetone acrylamide-methacrylic acid copolymer and aminoethylaminopropylmethylsiloxane- dimethylsiloxane copolymer; trade name: SETSIL314, from
Dow Corning Toray Co. Ltd., 20 wt $%), (acrylates/(Ci-1s)

Claims (20)

: pile dE ep Foi a 5) CLAIMS: ’
1. A deodorant composition characterized by comprising: (A) 0.1 to 15 wt% of an antiperspirant component, and a : (B-1) 0.1 to 2.5 wt$% of an acrylic acid-based anionid) J polymer selected from among an ammonium (styrene/alkyl Tf, acrylate) copolymer, an ammonium alkyl acrylate copolymer, "py an octylamide acrylate-hydroxypropyl acrylate- <P butylaminoethyl methacrylate copolymer, an (afYky acrylate/diacetone acrylamide) copolymer-amodimethifcone, an (acrylates/(Cj-13) alkyl acrylate/(Ci-g) alkyl acry amide) copolymer or a salt thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof; wherein the weight ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.
2. The deodorant composition of claim 1, wherein the salt of an (acrylates/(Ci-13) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer is the 2-amino-2-methyl-l-propanol salt of an (acrylates/(Ci-13) alkyl acrylate/(Ci-s) alkyl acrylamide) copolymer, and the salt of an (alkyl acrylate/diacetone acrylamide) copolymer is the 2-amino-2- methyl-1,3-propanediol salt of an (alkyl acrylate/diacetone acrylamide) copolymer.
3. The deodorant composition of claim 1 or 2, wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-1) is from 0.3 to 2 wt % of the overall composition.
4. The deodorant composition of claim 1 or 2, wherein component (A) is chlorohydroxyaluminum.
5. The deodorant composition of claim 1 or 2 which further comprises (C) a powder.
6. The deodorant composition of claim 5, wherein component (C) is a powder selected from among talc and magnesia-silica.
7. The deodorant composition of claim 5, wherein the content of component (C) is 0.1 to 3 wt% of the overall composition.
8. The deodorant composition of claim 1 or 2 which is in gel or liquid form.
9. The deodorant composition of claim 1 or 2 which contains water and the content thereof is 12.2 to 27.85 wt%.
10. The deodorant composition of claim 1 or 2 which is to be filled in a roll-on, gel, lotion or mist container.
11. A deodorant composition characterized by comprising: (A) 0.1 to 15 wt% of an antiperspirant component, and (B-2) 0.1 to 5 wt% of a vinyl acetate-based anionic polymer selected from among a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer, a (vinyl methyl ether/ethyl maleate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer; wherein the weight ratio of component (B-2) to component (A), expressed as (B- 2)/(A), is from 0.05 to 10.
12. The deodorant composition of claim 11, wherein component (B-2) is a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer.
13. The deodorant composition of claim 11 or 12, wherein the content of component (A) is from 1.5 to 10 wt% of the overall composition and the content of component (B-2) is from 1 to 4 wt% of the overall composition.
14. The deodorant composition of claim 11 or 12, wherein component (A) is chlorohydroxyaluminum.
15. The deodorant composition of claim 11 or 12 which further comprises (C) a powder.
16. The deodorant composition of claim 15, wherein component (C) is a powder selected from among talc and magnesia-silica.
17. The deodorant composition of claim 15, wherein the content of component (C) is 0.1 to 13 wt% of the overall composition.
18. The deodorant composition of claim 11 or 12 which is in gel or liquid form.
19. The deodorant of composition of claim 11 or 12 which contains water and the content thereof is 12.2 to 27.85 wts.
20. The deodorant composition of claim 11 or 12 which is to be filled in a roll-on, gel, lotion or mist container.
PH12014501211A 2011-11-29 2014-05-29 Deodorant composition PH12014501211B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011260213 2011-11-29
PCT/JP2012/080941 WO2013081055A1 (en) 2011-11-29 2012-11-29 Deodorant composition

Publications (2)

Publication Number Publication Date
PH12014501211A1 PH12014501211A1 (en) 2014-09-08
PH12014501211B1 true PH12014501211B1 (en) 2014-09-08

Family

ID=48535504

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501211A PH12014501211B1 (en) 2011-11-29 2014-05-29 Deodorant composition

Country Status (4)

Country Link
JP (1) JP6070571B2 (en)
MY (1) MY165096A (en)
PH (1) PH12014501211B1 (en)
WO (1) WO2013081055A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452396B2 (en) * 2013-11-14 2019-01-16 ライオン株式会社 Antiperspirant composition
FR3015269B1 (en) * 2013-12-20 2016-01-01 Oreal COMPOSITION COMPRISING A PARTICULAR ACRYLIC COPOLYMER AND A POLYMER FIXING AMPHOTERE
EP3082967A2 (en) * 2013-12-20 2016-10-26 L'oreal Composition comprising a specific acrylic copolymer and a fixing polymer chosen from anionic fixing polymers comprising crotonic acid as a monomer, non ionic and non silicone fixing polymers, and amphoteric fixing polymers
JP6594759B2 (en) * 2015-12-11 2019-10-23 ライオン株式会社 Antiperspirant composition
JP6660258B2 (en) * 2016-06-20 2020-03-11 ライオン株式会社 Antiperspirant composition
JP6900122B2 (en) * 2018-03-16 2021-07-07 株式会社マンダム Antiperspirant composition and antiperspirant
WO2019176265A1 (en) * 2018-03-16 2019-09-19 株式会社マンダム Antiperspirant composition, and antiperspirant
JP7393925B2 (en) * 2019-11-25 2023-12-07 花王株式会社 Skin external preparations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404844D0 (en) * 1984-02-24 1984-03-28 Unilever Plc Skin treatment composition
IL105748A0 (en) * 1992-05-22 1993-09-22 Int Research & Dev Corp Topical antiperspirant composition
US5534245A (en) * 1994-02-22 1996-07-09 Helene Curtis, Inc. Antiperspirant deodorant compositions
JP2889377B2 (en) * 1995-11-21 1999-05-10 シチズン時計株式会社 Driving circuit for inkjet head and driving method thereof
JP3686756B2 (en) * 1998-03-31 2005-08-24 株式会社資生堂 Antiperspirant
GB0213999D0 (en) * 2002-06-18 2002-07-31 Unilever Plc Antiperspirant emulsion compositions
US7404946B2 (en) * 2003-11-21 2008-07-29 The Procter And Gamble Company Antiperspirant methods and compositions
JP4493449B2 (en) * 2004-09-02 2010-06-30 三菱鉛筆株式会社 Eye makeup cosmetics
JP2009292772A (en) * 2008-06-05 2009-12-17 Mandom Corp Eyelash cosmetic
JP5502368B2 (en) * 2009-05-28 2014-05-28 花王株式会社 hair spray
CN102596168A (en) * 2009-08-31 2012-07-18 株式会社资生堂 Cosmetic preparation for hair styling
JP2011126862A (en) * 2009-11-18 2011-06-30 Lion Corp Cosmetic
FR2954151B1 (en) * 2009-12-17 2012-03-16 Oreal USE OF A COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILMOGENEOUS ELASTOMERIC POLYMER FOR THE TREATMENT OF HUMAN TRANSPIRATION
JP2011157285A (en) * 2010-01-29 2011-08-18 Re & Do Kk Hair growing tonic

Also Published As

Publication number Publication date
JP6070571B2 (en) 2017-02-01
PH12014501211A1 (en) 2014-09-08
JPWO2013081055A1 (en) 2015-04-27
WO2013081055A1 (en) 2013-06-06
MY165096A (en) 2018-02-28

Similar Documents

Publication Publication Date Title
PH12014501211B1 (en) Deodorant composition
KR101795896B1 (en) Body odor suppressing agent
JP6452396B2 (en) Antiperspirant composition
JP5895478B2 (en) Liquid-based sweat deodorant composition and liquid-based sweat deodorant product
JP5550863B2 (en) Cosmetics
US20120184628A1 (en) O/w type cosmetic composition with improved dosage form stability
JP2021035997A (en) Odor gas reducing agent
JP2017048140A (en) Antiperspirant composition
JP5825053B2 (en) Liquid-based sweat deodorant composition
CN111182885A (en) Dust control composition
KR102062200B1 (en) Scalp composition, scalp cosmetic and coating method
JP6900122B2 (en) Antiperspirant composition and antiperspirant
JP2017122059A (en) Body odor suppressing agent
JP6618401B2 (en) Emulsion odor control agent
JP6284437B2 (en) Body odor suppressor
JP6900121B2 (en) Antiperspirant composition and antiperspirant
JP6660258B2 (en) Antiperspirant composition
JP6613123B2 (en) Antiperspirant deodorant composition
JP6895584B2 (en) Powder-containing body odor suppressant
JP6909353B2 (en) Powder-containing external preparation for skin
JP7475785B2 (en) Oil-in-water emulsion composition
CA3001437A1 (en) Anti-perspirant composition
WO2021085059A1 (en) Antiperspirant composition
JP2022080515A (en) Antiperspirant composition
JP2014218475A (en) Antiperspirant composition